Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With Dupilumab.

Soria, Angèle; Du-Thanh, Aurélie; Seneschal, Julien; Jachiet, Marie; Staumont-Sallé, Delphine; Barbarot, Sébastien; GREAT Research Group · JAMA Dermatol · 2019

prospective_cohort · Level II

Where this comes from

Record sourced from PubMed, PMID 31483439.
Also identified by DOI 10.1001/jamadermatol.2019.2613 and PMC identifier 6727675.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

This cohort study describes the development or exacerbation of head and neck dermatitis in patients treated with dupilumab for atopic dermatitis.

Read the full text

View on PubMed · Publisher (DOI)